Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis

International Journal of Cardiology

Volumn 191, Issue , 2015, Pages 187-193

  Pavasini, Rita ^a   D'Ascenzo, Fabrizio ^b   Campo, Gianluca ^a,c   Biscaglia, Simone ^a   Ferri, Alessandra ^a   Contoli, Marco ^d   Papi, Alberto ^d   Ceconi, Claudio ^a   Ferrari, Roberto ^a,e  

^a Cardiovascular Institute   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^c Laboratorio per le Tecnologie delle Terapie Avanzate   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e MARIA CECILIA HOSPITAL   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Mortality; Outcome; Troponin

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T;

ANALYTICAL PARAMETERS; ARTICLE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RISK ASSESSMENT; SYSTEMATIC REVIEW; TROPONIN CARDIAC LEVEL; ACUTE DISEASE; BLOOD; DISEASE COURSE; HOSPITAL ADMISSION; META ANALYSIS; OBSERVATIONAL STUDY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRENDS;

ACUTE DISEASE; DISEASE PROGRESSION; HUMANS; MORTALITY; OBSERVATIONAL STUDIES AS TOPIC; PATIENT ADMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TROPONIN T;

EID: 84951292251     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.05.006     Document Type: Article

References (32)

1. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur. Heart J. 35 Oct 1 2014 2541 2619
2. Global initiative for chronic obstructive lung disease - global strategy for the diagnosis, management and prevention for chronic obstructive pulmonary disease 2014
3. B. Zvezdin, S. Milutinov, M. Kojicic, and et al. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation Chest 136 2009 376 380
4. G.C. Donaldson, J.R. Hurst, C.J. Smith, R.B. Hubbard, and J.A. Wedzicha Increased risk of myocardial infarction and stroke following exacerbation of COPD Chest 137 2010 1091 1097
5. G. Campo, P. Guastaroba, A. Marzocchi, and et al. Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention Chest 144 2013 750 757
6. C. Baillard, M. Boussarsar, J.P. Fosse, and et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease Intensive Care Med. 29 2003 584 589
7. P.H. Brekke, T. Omland, S.H. Holmedal, and et al. Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Eur. Respir. J. 31 2008 563 570
8. O. Fruchter, and M. Yigla Cardiac troponin-I predicts long-term mortality in chronic obstructive pulmonary disease COPD 6 2009 155 161
9. C.S. Martins, M.J. Rodrigues, V.P. Miranda, and J.P. Nunes Prognostic value of cardiac troponin I in patients with COPD acute exacerbation Neth. J. Med. 67 2009 341 349
10. C.L. Chang, S.C. Robinson, G.D. Mills, and et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD Thorax 66 2011 764 768
11. A.D. Hoiseth, A. Neukamm, B.D. Karlsson, and et al. Elevated high sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease Thorax 66 2011 775 781
12. R. Marcun, A. Sustic, P.M. Brguljan, and et al. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease Int. J. Cardiol. 161 2012 156 159
13. A.M. Kelly, and S. Klim Is elevated troponin associated with in-hospital mortality in emergency department patients admitted with chronic obstructive pulmonary disease? Eur. J. Emerg. Med. 20 2013 54 57
14. Rahim I. Abdel, A.R.I. Youssef, A.S.A. Hassan, R. El-Ghamry, and A.E. Ahmed Serum troponin-I as a prognostic marker in acute exacerbated chronic obstructive pulmonary disease patients Egypt. J. Chest Dis. Tuberc. 62 2013 549 555
15. G. Campo, R. Pavasini, M. Malagù, S. Punzetti, N. Napoli, F. Guerzoni, A. Papi, C. Ceconi, and M. Contoli Relationship between troponin elevation, cardiovascular history and adverse events in patients with acute exacerbation of COPD COPD Mar 16 2015 (Epub ahead of print)
16. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement Lancet 354 1999 1896 1900
17. D.F. Stroup, J.A. Berlin, S.C. Morton, and et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
18. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.0.2 2009 The Cochrane Collaboration (http://handbook.cochrane.org/)
19. A. Liberati, D.G. Altman, J. Tetzlaff, and et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
20. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control. Clin. Trials 7 1986 177 188
21. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
22. A.D. Høiseth, A. Neukamm, T.A. Hagve, T. Omland, P.H. Brekke, and V. Søyseth The clinical value of serial measurement of high-sensitivity cardiac troponin T in acute exacerbations of chronic obstructive pulmonary disease Open Heart 1 2014 e000001
23. G. Campo, R. Pavasini, M. Malagù, and et al. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management Cardiovasc. Drugs Ther. 29 2015 147 157
24. P. Boschetto, B. Beghé, L.M. Fabbri, and C. Ceconi Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice Respirology 17 2012 422 431
25. N.M. Hawkins, S. Virani, and C. Ceconi Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services Eur. Heart J. 34 2013 2795 2803
26. J.M. White, and R.A. Stewart Troponin elevation during exacerbations of chronic obstructive airways disease due to stress cardiomyopathy Int. J. Cardiol. 160 2012 206 207
27. G. Campo, R. Pavasini, A. Pollina, M. Tebaldi, and R. Ferrari On-treatment platelet reactivity in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention Thorax 69 2014 80 81
28. A.D. Høiseth, T. Omland, T.A. Hagve, P.H. Brekke, and V. Søyseth Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: a prospective cohort study BMC Pulm. Med. 12 2012 22 29
29. V. Søyseth, R. Bhatnagar, N.H. Holmedahl, and et al. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T Heart 99 2013 122 126
30. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) ESC guidelines on the diagnosis and management of acute pulmonary embolism Eur. Heart J. 35 2014 3033 3069
31. M.T. Harrison, P. Short, P.A. Williamson, A. Singanayagam, J.D. Chalmers, and S. Schembri Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy? Thorax 69 2014 609 615
32. G.J. Criner, J.E. Connett, S.D. Aaron, and et al. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD N. Engl. J. Med. 370 2014 2201 2210